• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVE DIVISION HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVE DIVISION HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T505C225
Device Problems Improper or Incorrect Procedure or Method (2017); Misassembly by Users (3133)
Patient Problem Not Applicable (3189)
Event Date 01/19/2018
Event Type  Injury  
Manufacturer Narrative
Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that this patient underwent a complex cardiac operation, involving an aortic root replacement (medtronic bioprosthetic valve inside of a non-medtronic tube graft), triple coronary artery bypass grafting (cabg), and the implantation of a temporary epicardial pacing wire.After the initial implant of the bioprosthetic valve, an intra-operative transesophageal echocardiogram (tee) demonstrated the valve was functioning as expected.The chest was closed and the patient was transferred from the operating room in stable condition.Approximately 35 minutes post-operative, the surgical team realized the valve holder of the bioprosthetic valve was not removed prior to closing the patient and remained attached to the valve.The patient was then transferred back to the operating room and underwent an additional procedure where the valve holder was successfully located and removed.An intra-operative transesophageal echocardiogram (tee) revealed the valve was functioning as expected.The patient was transferred from the operating room in stable condition.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVE DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVE DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key7868327
MDR Text Key119949436
Report Number2025587-2018-02402
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/28/2021
Device Model NumberT505C225
Device Catalogue NumberT505C225
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/14/2018
Initial Date FDA Received09/12/2018
Date Device Manufactured11/29/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-